Estrogen-induced rat pituitary tumor is associated with loss of retinoblastoma susceptibility gene product

Molecular and Cellular Endocrinology

Volumn 146, Issue 1-2, 1998, Pages 87-92

  Chun, Tae Yon ^a   Wendell, Douglas ^a   Gregg, David ^a   Gorski, Jack ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cyclin; Diethylstilbestrol; PRb

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ESTROGEN METABOLISM; HORMONAL REGULATION; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, WESTERN; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; DIETHYLSTILBESTROL; DISEASE SUSCEPTIBILITY; ESTRADIOL; IMMUNOSORBENT TECHNIQUES; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS; RATS; RATS, INBRED BN; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN;

EID: 0032567145     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00193-2     Document Type: Article

References (35)

1. Altucci P., Addeo R., Cicatiello L. et al. 17β-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene. 12:1996;2315-2324.
2. Bates S., Parry D., Bonetta L., Vousden K., Dickson C., Peters G. Absesnce of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene. 9:1994;1633-1640.
3. Cavanaugh A., Hempel W., Taylor L., Rogalsky V., Todorov G., Rothblum L. Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature. 374:1995;177-180.
4. Cavenee W.K., Dryja T.P., Phillips R.A. et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305:1983;779-784.
5. Cavenee W.K., Hansen M.F., Nordenskjold M., Kock E., Maumenee I., Squire J.A., Phillips R.A., Gallie B.L. Genetic origin of mutations predisposing to retinoblastoma. Science. 228:1985;501-503.
6. Chang C.-Y., Riley D.J., Lee E.Y.-P., Lee W.-H. Quantitative aspects of the retinoblastoma gene on mouse development and tissue-specific tumorigenesis. Cell Growth Differ. 4:1993;1057-1064.
7. Chun T.-Y., Gregg D., Sarkar D.K., Gorski J. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth. Proc. Natl. Acad. Sci. USA. 95:1998;2325-2330.
8. Elias K.A., Weiner R.I. Direct arterial vasculaization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc. Natl. Acad. Sci. USA. 81:1984;4549-4553.
9. Foster J., Wimalasena J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol. 10:1996;488-498.
10. Gottardis M., Saceda M., Garcia-Morales P. et al. Regulation of retinoblastoma gene expression in hormone-dependent breast cancer. Endocrinology. 136:1995;5659-5665.
11. Gregg D., Goedken E., Galkin M., Wendell D., Gorski J. Decreased expression of carboxypeptidase E protein is correlated to estrogen-induction of rat pituitary tumors. Mol. Cell Endocrinol. 117:1996;219-225.
12. Harvey M., Vogel H., Lee E.Y.-H., Bradley A., Donehower L.A. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res. 55:1995;1146-1151.
13. Horowitz J.M., Park S.-H., Bogenmann E. et al. Frequent inactivation of the retinoblastoma antioncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA. 87:1990;2775-2779.
14. Hu N., Gutsmann A., Herbert D., Bradley A., Lee W., Lee E. Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with nearly complete penetrance. Oncogene. 9:1994;1021-1027.
15. Koh J., Enders G., Dynlacht B., Harlow E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature. 375:1995;506-510.
16. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
17. Livingstone L.R., White A., Spouse J., Livanos E., Jack T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild type p53. Cell. 70:1992;923-935.
18. Lloyd R.V. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am. J. Pathol. 113:1983;198-206.
19. Lloyd R.V., Mailloux J. Effects of diethylstilbestrol and propylthiouracil on the rat pituitary. An immunohistochemical and ultrastructural study. J. Natl. Cancer Inst. 79:1987;865-873.
20. Lukas J., Parry D., Aagaard L. et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 375:1995;503-506.
21. Maxwell S. Retinoblastoma protein in non-small cell lung carcinoma cells arrested for growth by retinoic acid. Anticancer Res. 14:1994;1535-1540.
22. Pastorcic M., De A., Boyadjieva N., Vale W., Sarkar D.K. Reduction in the expression and action of tranforming growth factor β1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res. 55:1995;4892-4898.
23. Schechter J., Weiner R. Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats. Endocrinology. 129:1991;2400-2408.
24. Shepel L., Gorski J. Relationship of polymorphisms near the rat prolactin, N-ras, and retinoblastoma genes with susceptibility to estrogen-induced pituitary tumors. Cancer Res. 50:1990a;7920-7925.
25. Shepel L., Gorski J. Restriction fragment length polymorphisms in the rat N-ras and retinoblastoma genes: their identification and characterization. Oncogene. 5:1990b;1675-1682.
26. Watts C., Brady A., Sarcevic B., deFazio A., Musgrove E., Sutherland R. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblatoma protein phosphorylation. Mol. Endocrinol. 9:1995;1804-1813.
27. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
28. Wendell D., Herman A., Gorski J. Genetic separation of tumor growth and hemorrhagic phenotypes in an estrogen-induced tumor. Proc. Natl. Acad. Sci. USA. 93:1996;8112-8116.
29. White R.J., Trouche D., Martin K., Jackson S.P., Kouzardies T. Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature. 382:1996;88-90.
30. Wiklund J., Rutledge J., Gorski J. A genetic model for the inheritance of pituitary tumor susceptibility in F344 rats. Endocrinology. 109:1981a;1708-1714.
31. Wiklund J., Wertz N., Gorski J. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology. 109:1981b;1700-1707.
32. Woloschak M., Yu A., Xiao J., Post K. Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors. Int. J. Cancer. 67:1996a;16-19.
33. Woloschak M., Yu A., Xiao J., Post K. Frequent loss of the P16 ink4a gene product in human pituitary tumors. Cancer Res. 56:1996b;2493-2496.
34. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70:1992;937-948.
35. Ying C., Gregg D., Gorski J. Estrogen-induced changes in rRNA accumulation and RNA polymerase I activity in the rat pituitary: correlation with pituitary tumor susceptibility. Mol. Cell Endocrinol. 118:1996;207-213.